The efficacy of NTD Labs’ patented Ultra-Screen protocol for first trimester Down syndrome screening has been scientifically proven in 18 clinical trials and 2 NIH-sponsored studies involving more than 190,000 patients nationwide.
BUN Study
FASTER Study
SURUSS Study